AbbVie’s newest psoriasis awareness-raising campaign is taking the skin condition out of the spotlight. | AbbVie’s newest ...

Right on the heels of a similar move by Johnson & Johnson, GSK is offloading the rest of its stake in the consumer healthcare ...

The momentum the biopharma industry showed in the fourth quarter of 2023 has continued into this year. | The momentum the ...

As it prepares to push its kidney care portfolio out of the nest, Baxter International isn’t branching out too widely with ...

After admitting to the crime four years ago, a former Sandoz executive will avoid hard time for his part in a generic drug ...

The FDA has broadened the use of Bristol Myers Squibb’s CAR-T therapy Breyanzi to another type of blood cancer. | The FDA has ...

A fire broke out Thursday on the roof of a building under construction at Novo Nordisk’s key manufacturing hub in Kalundborg, ...

Launched amid NF Awareness Month this May, its new campaign “Coping isn’t Care” is aimed at boosting knowledge of ...

AstraZeneca is yet to put allegations of unequal pay behind it. | AstraZeneca is yet to put allegations of unequal pay behind ...

Shields replaces Eric Drapé, who is stepping down from the company after working there for more than a decade, the company ...

After recently placing a spotlight on Novo Nordisk’s "outrageous" U.S. | A new Senate HELP Committee report says GLP-1 drugs ...

Lundbeck has learned an unwanted lesson in the value of DTC advertising. | Lundbeck has learned an unwanted lesson in the ...